Lingyan Ping

A safe and potent anti-CD19 CAR T cell therapy

Zhitao Ying, Xue F. Huang, Xiaoyu Xiang et al. · Nature Medicine · 2019 · 435 citations · Full text

Cell Therapy, Immunology, Autoimmunity +2

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma

Zhitao Ying, Ting He, Xiaopei Wang et al. · Molecular Therapy — Oncolytics · 2019 · 163 citations · Full text

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin

Lijuan Deng, Yuqin Song, Ken H. Young et al. · Oncotarget · 2015 · 95 citations · Full text

The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages

Lingyan Ping, Ning Ding, Yunfei Shi et al. · Oncotarget · 2017 · 85 citations · Full text

A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type

Ningjing Lin, Yuqin Song, Wen Zheng et al. · Journal of Hematology & Oncology · 2013 · 69 citations · Full text